drugset / Trial / NCT01084330
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
A clinical trial to determine the effectiveness and safety of AUY922 compared to other drugs known to be effective against gastric cancer in second line therapy for patients who have failed one line of chemotherapy.
Timeline
- Start
- 2010-04
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AUY922 | Small molecule | 70 mg/m2 | — |
| Comparator | Docetaxel | Small molecule | 75 mg/m2 | — |
| Comparator | Irinotecan | Small molecule | 350 mg/m2 | — |